Mental Health

With the smart tablets coming to market in 2018, it is a good time to explore how the technology behind the product works.

Aripiprazole tablets with sensor (Abilify MyCite) is approved to treat schizophrenia, manic and mixed episodes for patients with bipolar I disorder, and as an add-on for depression treatment.

Aripiprazole tablets with sensor (Abilify MyCite) transmits information to an app when ingested.

Cariprazine is a once-daily atypical antipsychotic for patients with bipolar I disorder and schizophrenia.

Here is how to go beyond conventional medicine to help those who suffer from the leading mental health disorder in the United States.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Only 38% of parents are very confident that school staff can help a student with a suspected mental health problem.

Top news of the day from across the healthcare landscape.

Over the years, a number of landmark clinical studies in the field of psychiatry have been published, shaping how we treat mental illness. Here are 5 that every pharmacist should know about.

According to the US Preventive Services Task Force's (USPSTF) updated recommendations for depression screening in adults, major depressive disorder is the leading cause of disability among adults in high-income countries.

Here is the 411 on this organization, which offers programs to help consumers better understand their medications.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Aripiprazole (Abilify Maintena) found to delay manic episodes in adults with bipolar 1 disorder.

Top news of the day from across the healthcare landscape.

Severe mental illness may increase the risk of heart disease more than 50%.

Pregabalin and gabapentin involved with numerous heroin overdoses.

What are the best practice considerations for managing Parkinson's Psychosis?

The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia.

This article highlights 5 published case reports that document unusually high doses of medications that are not often seen in clinical practice.

Clinicians should provide extra attention to patients with heart disease and depression.

Kynurenic acid observed to indirectly raise glutamate levels.

Anxiety and depression linked to longer time living with HIV.

Top news of the day from across the health care landscape.

What are you doing to stop the stigma surrounding mental illnesses?

A new physiologically based assay shows the role of neuropeptide Y in post-traumatic stress disorder and other anxiety disorders.

What can you (or your pharmacist) do to improve Bipolar I Disorder outcomes?